103 related articles for article (PubMed ID: 28463858)
1. Physical long-term side-effects in young adult cancer survivors: germ cell tumors model.
Kourie HR; Klastersky JA
Curr Opin Oncol; 2017 Jul; 29(4):229-234. PubMed ID: 28463858
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy-induced toxicity in patients with testicular germ cell tumors: The impact of physical fitness and regular exercise.
Amiri A; Chovanec M; Oliva V; Sedliak M; Mego M; Ukropec J; Ukropcová B
Andrology; 2021 Nov; 9(6):1879-1892. PubMed ID: 34245663
[TBL] [Abstract][Full Text] [Related]
3. Medical treatment of advanced testicular cancer.
Feldman DR; Bosl GJ; Sheinfeld J; Motzer RJ
JAMA; 2008 Feb; 299(6):672-84. PubMed ID: 18270356
[TBL] [Abstract][Full Text] [Related]
4. Long-term toxicity of the treatment for germ cell-cancer. A review.
Maroto P; Anguera G; Martin C
Crit Rev Oncol Hematol; 2018 Jan; 121():62-67. PubMed ID: 29279100
[TBL] [Abstract][Full Text] [Related]
5. Long-term toxicity of cisplatin in germ-cell tumor survivors.
Chovanec M; Abu Zaid M; Hanna N; El-Kouri N; Einhorn LH; Albany C
Ann Oncol; 2017 Nov; 28(11):2670-2679. PubMed ID: 29045502
[TBL] [Abstract][Full Text] [Related]
6. Age-related variation and predictors of long-term quality of life in germ cell tumor survivors.
Hartung TJ; Mehnert A; Friedrich M; Hartmann M; Vehling S; Bokemeyer C; Oechsle K
Urol Oncol; 2016 Feb; 34(2):60.e1-6. PubMed ID: 26480898
[TBL] [Abstract][Full Text] [Related]
7. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
[TBL] [Abstract][Full Text] [Related]
8. "Chronic fatigue, quality of life and long-term side-effects of chemotherapy in patients treated for non-epithelial ovarian cancer: national case-control protocol study of the GINECO-Vivrovaire rare tumors INCa French network for rare malignant ovarian tumors".
Gernier F; Ahmed-Lecheheb D; Pautier P; Floquet A; Nadeau C; Frank S; Alexandre J; Selle F; Berton-Rigaud D; Kalbacher E; Orfeuvre H; Lortholary A; Augereau P; Labombarda F; Perrier L; Grellard JM; Licaj I; Clarisse B; Savoye AM; Bourien H; De La Motte Rouge T; Kurtz JE; Kerdja K; Lelaidier A; Charreton A; Ray-Coquard I; Joly F
BMC Cancer; 2021 Oct; 21(1):1147. PubMed ID: 34702204
[TBL] [Abstract][Full Text] [Related]
9. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up.
Haugnes HS; Bosl GJ; Boer H; Gietema JA; Brydøy M; Oldenburg J; Dahl AA; Bremnes RM; Fosså SD
J Clin Oncol; 2012 Oct; 30(30):3752-63. PubMed ID: 23008318
[TBL] [Abstract][Full Text] [Related]
10. Pulmonary and cardiovascular toxicity in long-term testicular cancer survivors.
Haugnes HS; Oldenburg J; Bremnes RM
Urol Oncol; 2015 Sep; 33(9):399-406. PubMed ID: 25554583
[TBL] [Abstract][Full Text] [Related]
11. Treatment of testicular cancer and the development of secondary malignancies.
Bokemeyer C; Schmoll HJ
J Clin Oncol; 1995 Jan; 13(1):283-92. PubMed ID: 7799032
[TBL] [Abstract][Full Text] [Related]
12. Long-term Morbidity of Testicular Cancer Treatment.
Fung C; Fossa SD; Williams A; Travis LB
Urol Clin North Am; 2015 Aug; 42(3):393-408. PubMed ID: 26216826
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two standard chemotherapy regimens for good-prognosis germ cell tumors: updated analysis of a randomized trial.
Grimison PS; Stockler MR; Thomson DB; Olver IN; Harvey VJ; Gebski VJ; Lewis CR; Levi JA; Boyer MJ; Gurney H; Craft P; Boland AL; Simes RJ; Toner GC
J Natl Cancer Inst; 2010 Aug; 102(16):1253-62. PubMed ID: 20631341
[TBL] [Abstract][Full Text] [Related]
14. Treatment-related cardiovascular late effects and exercise training countermeasures in testicular germ cell cancer survivorship.
Christensen JF; Bandak M; Campbell A; Jones LW; Højman P
Acta Oncol; 2015 May; 54(5):592-9. PubMed ID: 25751759
[TBL] [Abstract][Full Text] [Related]
15. Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer.
van den Belt-Dusebout AW; Nuver J; de Wit R; Gietema JA; ten Bokkel Huinink WW; Rodrigus PT; Schimmel EC; Aleman BM; van Leeuwen FE
J Clin Oncol; 2006 Jan; 24(3):467-75. PubMed ID: 16421423
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term outcomes after large pulmonary resection for germ cell tumors after bleomycin-combination chemotherapy.
Andrade RS; Kesler KA; Wilson JL; Brooks JA; Reichwage BD; Rieger KM; Einhorn LH; Brown JW
Ann Thorac Surg; 2004 Oct; 78(4):1224-8; discussion 1228-9. PubMed ID: 15464475
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors.
Ishioka J; Fujii Y; Kageyama Y; Fukuda H; Higashi Y; Kihara K
Int J Urol; 2008 Jul; 15(7):642-5. PubMed ID: 18643784
[TBL] [Abstract][Full Text] [Related]
18. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis.
Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE
J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800
[TBL] [Abstract][Full Text] [Related]
19. Secondary malignant neoplasms in testicular cancer survivors.
Curreri SA; Fung C; Beard CJ
Urol Oncol; 2015 Sep; 33(9):392-8. PubMed ID: 26072728
[TBL] [Abstract][Full Text] [Related]
20. Management of good risk germ-cell tumours.
Troost MM; Sternberg CN; de Wit R
BJU Int; 2009 Nov; 104(9 Pt B):1387-91. PubMed ID: 19840018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
